Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.310
-0.090 (-6.43%)
At close: Nov 20, 2024, 4:00 PM
1.319
+0.009 (0.67%)
After-hours: Nov 20, 2024, 4:03 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $5.86 million as of November 21, 2024. Its market cap has decreased by -47.26% in one year.
Market Cap
5.86M
Enterprise Value
4.67M
1-Year Change
-47.26%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $5.86M, a decrease of -99.49%. That is a compound annual growth rate of -78.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 5.86M | -7.49% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongchao | 6.10M |
| Intelligent Bio Solutions | 6.03M |
| Syros Pharmaceuticals | 5.95M |
| Ainos | 5.95M |
| CNS Pharmaceuticals | 5.89M |
| Cutera | 5.88M |
| SunLink Health Systems | 5.87M |
| Organovo Holdings | 5.80M |